Phorbol-12-Myristate-13-Acetate-Induced Protein 1 (PMAIP1) (N-Term) Peptid
PMAIP1
Reaktivität: Human
BP
Sodium azide
-
- Target Alle NOXA (PMAIP1) Produkte
- NOXA (PMAIP1) (Phorbol-12-Myristate-13-Acetate-Induced Protein 1 (PMAIP1))
- Protein Region
- N-Term
- Spezies
- Human
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
-
17 amino acids near the amino terminus of human Noxa.
Human
-
-
- Applikationshinweise
- Noxa peptide is used for blocking the activity of Noxa.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Haltbarkeit
- 12 months
-
- Target
- NOXA (PMAIP1) (Phorbol-12-Myristate-13-Acetate-Induced Protein 1 (PMAIP1))
- Synonyme
- TN3 Peptide, PMAIP1 Peptide, zgc:162379 Peptide, APR Peptide, NOXA Peptide, Noxa Peptide, phorbol-12-myristate-13-acetate-induced protein 1 Peptide, PMAIP1 Peptide, pmaip1 Peptide, Pmaip1 Peptide
-
Sie sind hier:
